ASXL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CRISPR/Cas9-based correction of the ASXL1 mutation found in the CML KBM5 cell line restored the expression of the ASXL1 protein which is normally absent in myeloid cell lines carrying homozygous nonsense ASXL1 mutations [13].